ethylisopropylamiloride has been researched along with Ventricular Fibrillation in 2 studies
ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.
Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chorro, FJ | 1 |
| Canto, ID | 1 |
| Brines, L | 1 |
| Such-Miquel, L | 1 |
| Calvo, C | 1 |
| Soler, C | 1 |
| Zarzoso, M | 1 |
| Trapero, I | 1 |
| Tormos, Á | 1 |
| Such, L | 1 |
| Yasutake, M | 1 |
| Ibuki, C | 1 |
| Hearse, DJ | 1 |
| Avkiran, M | 1 |
2 other studies available for ethylisopropylamiloride and Ventricular Fibrillation
| Article | Year |
|---|---|
Experimental Study of the Effects of EIPA, Losartan, and BQ-123 on Electrophysiological Changes Induced by Myocardial Stretch.
Topics: Amiloride; Angiotensin II Type 1 Receptor Blockers; Animals; Endothelin Receptor Antagonists; Epithe | 2015 |
Na+/H+ exchange and reperfusion arrhythmias: protection by intracoronary infusion of a novel inhibitor.
Topics: Amiloride; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Circulation; Electrocardi | 1994 |